Pharmacyclics, Inc. Share Price
Equities
US7169331060
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2015 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
2015 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 30/04/15 | |
Betty Chang
CTO | Chief Tech/Sci/R&D Officer | - | 08/07/13 |
Alvina Chu
PRN | Corporate Officer/Principal | - | - |
1st Jan change | Capi. | |
---|---|---|
+22.08% | 44.96B | |
+0.86% | 42.65B | |
+46.00% | 41.85B | |
-4.27% | 29.04B | |
+10.51% | 26.08B | |
-20.86% | 19.03B | |
+5.52% | 12.75B | |
+27.94% | 12.06B | |
-3.83% | 11.75B |
- Stock Market
- Equities
- Stock